Invest now

Alkem Laboratories Profit & Loss Annual

BSE: 539523 | NSE: ALKEM | ISIN: INE540L01014 | Sector: Biotechnology & Drugs
5,397.55 -21.20 (-0.39%)Updated : 14 Aug 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Total Operating Expense 12,189.3210,796.7110,681.0610,320.11
Other Net -12.01-11.91-12.13-12.36
Diluted Weighted Average Shares 11.9611.9611.9611.96
Gain( Loss)on Saleof Assets -1.504.60-3.18-12.36
Depreciation/ Amortization 382.06357.16299.30310.42
Operating Income 2,522.952,167.811,986.521,279.15
Net Income 2,301.802,165.481,795.77984.17
Income Availableto Com Excl Extra Ord 2,301.802,165.481,795.77984.17
Other Operating Expenses Total 201.85193.09256.9896.33
Net Income Before Taxes 2,868.922,526.412,023.131,304.77
Minority Interest -49.36-49.90-15.69-22.64
Net Income After Taxes 2,351.162,215.381,811.461,006.81
Income Availableto Com Incl Extra Ord 2,301.802,165.481,795.77984.17
Costof Revenue Total 5,297.245,013.725,190.715,094.38
Gross Profit 9,415.037,950.807,476.876,504.88
Interest Inc( Exp) Net- Non- Op Total 359.48365.9151.9250.34
Unusual Expense( Income) 174.8313.730.00105.15
Diluted Net Income 2,301.802,165.481,795.77984.17
DPS- Common Stock Primary Issue 53.0045.0040.0025.00
Provisionfor Income Taxes 517.76311.03211.67297.96
period Type ----
Net Income Before Extra Items 2,301.802,165.481,795.77984.17
Total Revenue 14,712.2712,964.5212,667.5811,599.26
period Length 12.0012.0012.0012.00
Revenue 14,712.2712,964.5212,667.5811,599.26
Selling/ General/ Admin Expenses Total 6,133.345,219.014,934.074,713.83
Diluted Normalized EPS 204.60181.78150.4389.90
Diluted EPS Excluding Extra Ord Items 192.51181.11150.1982.31
*All figures in crores except per share values
Recommended For You
Trending Stocks
5,098.20+155.20(3.14%)
1,102.85+20.85(1.93%)
2,024.95+23.05(1.15%)
1,072.00-24.05 (-2.19%)
310.50-4.95 (-1.57%)